SCHEMBL6835903

SCHEMBL6835903

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(Br)o1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
RAB9A P51151 4/20 0.70
NPC1 O15118 3/20 0.70
HPGD P15428 2/20 0.70
MAPT P10636 4/20 0.64
KDM4E B2RXH2 2/20 0.64
SMN1; SMN2 Q16637 3/20 0.60
GAA P10253 3/20 0.57
AKR1C2 P52895 2/20 0.56
AKR1C1 Q04828 2/20 0.56
AKR1C4 P17516 1/20 0.56
AKR1C3 P42330 1/20 0.56
POLB P06746 2/20 0.53
TSHR P16473 3/20 0.51
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11888590 0.82 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1HPGDMAPT
SCHEMBL6818580 0.80 ALDH1A1 (0.56) ALDH1A1RAB9AHPGDMAPTKDM4E
SCHEMBL6933566 0.79 CYP1A2 (0.61) ALDH1A1RAB9ANPC1HPGDMAPT
SCHEMBL6817708 0.79 RAB9A (0.63) ALDH1A1RAB9ANPC1HPGDKDM4E
SCHEMBL17166275 0.79 AKR1C2 (0.73) ALDH1A1MAPTKDM4EAKR1C2AKR1C1
SCHEMBL7544693 0.77 KDM4E (0.59) ALDH1A1HPGDMAPTKDM4EGAA
SCHEMBL6830698 0.76 KMT2A (0.60) ALDH1A1RAB9ANPC1HPGDMAPT
SCHEMBL9513479 0.76 MAPT (0.80) MAPTAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6821974 0.75 HPGD (0.56) ALDH1A1RAB9ANPC1HPGDMAPT
SCHEMBL6822791 0.75 CYP1A2 (0.56) ALDH1A1RAB9AHPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALDH1A1 170/4885RAB9A 4337/4885NPC1 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.